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Monocytes have been recently subdivided into three subsets: classical (CD14++CD16−), 
intermediate (CD14++CD16+), and non-classical (CD14+CD16++) subsets, but 
phenotypic and functional abnormalities of the three monocyte subsets in HIV-1 
infection have not been fully characterized, especially in acute HIV-1 infection (AHI). In 
the study, we explored the dynamic changes of monocyte subsets and their surface 
markers, and the association between monocyte subsets and the IFN-γ, interleukin 
(IL)-4, IL-17, and TNF-α producing CD4+ T cells in acute and chronic HIV-1-infected 
patients. We found that, in the acute HIV-1-infected individuals, the frequency of the 
intermediate CD14++CD16+ monocyte subsets, the CD163 density and HLA-DR 
density on intermediate CD14++CD16+ monocytes, and plasma soluble form of 
CD163 (sCD163) were significantly higher than that in healthy controls. Intermediate 
CD14++CD16+ monocyte subsets and their HLA-DR expression levels were inversely 
correlated with the CD4+ T cell counts, and the intermediate CD14++CD16+ monocytes 
were positively correlated with plasma sCD163. In contrast to the non-classical 
CD14+CD16++ and classical CD14++CD16− monocyte subsets, the frequency of the 
intermediate CD14++CD16+ monocytes was positively associated with the frequency 
of IFN-γ and IL-4 producing CD4+ T cells in HIV-1-infected patients. Taken together, 
our observations provide new insight into the roles of the monocyte subsets in HIV 
pathogenesis, particularly during AHI, and our findings may be helpful for the treatment 
of HIV-related immune activation.
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inTrODUcTiOn
The interactions between the virus and the immune system during acute HIV-1 infection (AHI) 
determine the viral load set point and other critical events. Monocytes can act as regulators 
of the immune system, and monocytes abnormalities are responsible for the hyperactivity 
observed in HIV-1-infected patients (1). In 2010, three monocyte subsets were recommended 
by the Nomenclature Committee of the International Union of Immunological Societies: classical 
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(CD14++CD16−), intermediate (CD14++CD16+), and non-
classical (CD14+CD16++) subsets (2). Phenotypic and func-
tional abnormalities of the three monocyte subsets have not 
been fully characterized in HIV-1 infection, especially in acute 
HIV-1 infection.
Identification of the three subsets within monocytes popu-
lations has put monocyte heterogeneity into sharp focus. The 
perturbation of the three monocyte subsets has been examined 
in various diseases including bacterial infection, viral infection, 
and autoimmune disease (3–5). Analysis of monocyte subsets 
may provide useful clinical parameters in various settings (6). 
In chronic HIV-1-infected patients, both the intermediate and 
non-classical subsets were increased, and intermediate subsets 
were inversely correlated with a decrease in CD4+ T-cell counts 
(7). In response to the exogenous and endogenous stimula-
tions, monocytes express a variety of surface markers. CD163 
is expressed exclusively on monocytes and macrophages, dur-
ing activation, CD163 can be shed as soluble form of CD163 
(sCD163) (8). It was found that CD163 expression levels on 
intermediate CD14++CD16+ monocytes of chronic HIV-1-
infected subjects were significantly higher than that of healthy 
controls (HC) (9). Plasma sCD163 was evaluated as an inde-
pendent marker of the progression to death and AIDS (10). In 
chronic HIV-1-infected individuals, there was a higher density 
of HLA-DR on monocytes, and combined antiretroviral therapy 
(cART) has decreased the density of HLA-DR on inflammatory 
monocytes (CD14+CD16+) (11). Until now, the perturbations 
of the three monocyte subsets and their surface markers have 
remained incompletely understood, especially in acute HIV-1-
infected individuals.
Depending on the cytokine environment, naïve CD4+ T cells 
differentiate into T helper (Th) 1, Th2, Th17, and other line-
ages, each lineage has distinct biological functions. In immune 
thrombocytopenia, CD16+ monocytes promoted Th1 develop-
ment, which in turn negatively regulated interleukin (IL)-17 and 
Treg induction (12). In rheumatoid arthritis, the CD14brightCD16 
monocyte subsets promoted an expansion of the Th17  cell 
population (13). The specific roles of the three monocyte subsets 
on Th cell differentiation have not been fully characterized in 
HIV-1-infected patients.
From 2007 to 2012, 484 acute HIV-1-infected cases among 
5,800 men who have sex with men (MSM) were identified by our 
team (14). We found that acute HIV-1 infection improved the 
immune responses against chronic hepatitis B (15). In the present 
study, we explored dynamic changes of the monocyte subsets and 
their surface markers, and the association between monocyte 
subsets and the IFN-γ, IL-4, IL-17, and TNF-α producing CD4+ 
T cells in acute and chronic HIV-1-infected patients.
MaTerials anD MeThODs
Patients
All the participants provided written informed consent for 
their information, and clinical samples were stored and used 
for research. This study and all relevant experiments have 
been approved by the Beijing You’an Hospital Research Ethics 
Committee and informed consent was provided according to the 
declaration of Helsinki. The methods were carried out in accord-
ance with approved guidelines and regulations.
Thirty-seven homosexual men with acute HIV-1 infec-
tion (AHI) were enrolled in the study, these patients were 
recruited from an HIV-1-negative high risk MSM cohort who 
were screened every 3  months for HIV-1 infection at Beijing 
You’an Hospital. The progression of early HIV-1 infection can 
be depicted as six discrete stages as proposed by Fiebig et  al. 
(16). These acute HIV-1-infected patients were at Fiebig stage 
III-V. Thirty-one chronic HIV-1-infected cART-naïve patients 
(CHI&ART−) and 63 chronic HIV-1-infected patients on cART 
(CHI&ART+) were randomly enrolled from the HIV/AIDS 
clinic of Beijing You’an Hospital. All HIV-1-infected patients in 
the study were MSM without HBV/HCV coinfection and other 
comorbidities, none of them were drug users. Chronic HIV-
1-infected patients were diagnosed at least 1.2  years (median 
1.8  years, range from 1.2 to 2.6  years) before enrollment. 
Sixty-three chronic HIV-1-infected patients in the study were 
treated with the following regimen: TDF+3TC+EFV, which 
was recommended as a first-line regimen in China. Sixty-three 
patients in the study have been on treatment for more than 
1  year, and the viral loads of these patients are undetectable. 
Forty-two male homosexual HC were also included in the study. 
The ages of all groups were matched.
cell surface and intracellular cytokine 
staining
Cryopreserved peripheral blood mononuclear cells (PBMCs) 
were used, and cell viability was evaluated in cell surface and 
intracellular cytokine staining experiment. Cryopreserved 
PBMCs were thawed in RPMI 1640 medium (Invitrogen, 
Carlsbad, CA, USA), washed with PBS containing 1% BSA, and 
then incubated at room temperature for 20  min with the cells 
viability marker fixable viability stain 510 (BD Biosciences, San 
Jose, CA, USA).
Monocyte phenotypic analysis was performed after staining 
with anti-CD14-FITC (eBioscience), anti-CD16-PE (eBiosci-
ence), anti-HLA-DR-PerCP-Cyanine5.5 (eBioscience), and 
anti-CD163-APC (eBioscience Inc., San Diego, CA, USA). 
Intracellular IFN-γ, IL-4, IL-17, and TNF-α staining was per-
formed after stimulating with a leukocyte activation cocktail 
with BD GolgiPlug (BD Bioscience, San Jose, CA, USA) for 5 h, 
the leukocyte activation cocktail contained PMA, ionomycin, 
and brefeldin A. Cells were initially stained with anti-CD4-PE-
Cy7 (eBioscience Inc., San Diego, CA, USA), cells were then 
fixed and permeablized with Cytofix/Cytoperm according to 
the manufacturer’s instructions (BD Biosciences, San Jose, CA, 
USA), followed by staining with anti-IL-4-PE (eBioscience), 
anti-IL-17-APC (eBioscience), anti-IFN-γ-eFluor 450 (eBiosci-
ence), anti-TNF-α-PerCP-Cyanine5.5 (eBioscience Inc., San 
Diego, CA, USA).
All expression analyses were performed by flow cytometry 
using BD FACSCanto™ II with Diva software (BD Biosciences, 
San Jose, CA, USA). Forward scatter and side scatter light gating 
were used to exclude cell debris from the analysis. Forward height 
TaBle 1 | characteristics of hiV-1-infected patients and healthy controls.
healthy  
control
acute hiV-1-infected  
patients
chronic carT-naïve  
hiV-1-infected patients
chronic hiV-1-infected 
patients with carT
Cases, no 42 37 31 63
Age (years) 29.6 (20–50) 31.4 (22–49) 30.3 (20–52) 32.8 (21–54)
HIV-RNA (copies/ml) NA 666,265.6 (3,685–5,536,452) 26,347.3 (567–147,548) TND
CD4 (cells/μl) 716 (427–1,322) 353 (137–497) 447 (238–756) 562 (176–897)
CD4/CD8 ratio 1.58 (0.63–2.59) 0.35 (0.12–1.58) 0.64 (0.24–1.62) 1.07 (0.33–2.36)
Data are presented as the means with ranges.
cART, combined antiretroviral therapy; NA, not available; TND, target not detected.
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and forward area were used to exclude doublet cells. The final 
analysis was performed using the Flowjo 10.0.7 software (Tree 
Star Inc., Ashland, OR, USA).
cD4+ T-cell count and Viral load 
Measurement
The CD4+ T-cell count was determined by using anti-CD3-
APC, anti-CD4-FITC, and anti-CD8-PE monoclonal antibodies 
(BD Biosciences). Analysis was then carried out using a BD 
FACSCanto™ II Flow cytometry (BD Biosciences, San Jose, 
CA, USA) system. HIV-1 viral load tests were done by using 
an automated real-time PCR-based m2000 system (Abbott 
Molecular Inc., Des Plaines, IL, USA) according to manufactur-
ers’ instruction, and the sensitivity of detection was 40 copies 
per milliliter.
Quantification of soluble cD163  
by Using elisa
Quantification of soluble CD163 (sCD163) was determined by 
using a commercial ELISA Kit (R&D Systems, Inc., USA) accord-
ing to the manufacturer’s instruction without modification.
statistical analysis
Statistical analysis was performed by using an ANOVA test, 
Student’s t-test, or non-parametric tests. All reported p values were 
two sided and considered significant at *p < 0.05 or **p < 0.01. 
The association was evaluated by Spearman’s correlation test. All 
data were analyzed using SPSS 21.0 statistical software (Chicago, 
IL, USA).
resUlTs
characteristics of Participants
Thirty-seven homosexual men with acute HIV-1 infection (AHI), 
31 CHI&ART-, 63 chronic HIV-1-infected patients with unde-
tectable viral load after cART (CHI&ART+), and 42 HC were 
enrolled in the study. The information of numbers, ages, viral 
loads, cell counts, and CD4+/CD8+ ratio is presented in Table 1. 
The age and sex of the HIV-1-infected patients and health con-
trols are matched, and the viral loads of the health controls are not 
available. The mean CD4 counts and CD4/CD8 ratio of HC are 
higher than those of the acute HIV-1-infected patients (p < 0.01) 
and higher than those of chronic HIV-1-infected patients without 
cART (p < 0.01).
Perturbations of the Three Monocyte 
subsets in hiV-1-infected individuals
Based on CD14 and CD16 expression, monocytes are divided 
into three subsets: classical (CD14++CD16−), intermediate 
(CD14++CD16+), and non-classical (CD14+CD16++) subsets. 
The gating strategy is shown in Figure 1A. As seen in Figure 1, 
compared with HC, intermediate CD14++CD16+ monocytes 
(Figure 1C) are increased in both AHI and CHI&ART− patients, 
whereas classical CD14++CD16− monocytes are decreased in 
AHI and CHI&ART− patients (Figure  1D). Although cART 
partially recovered the proportions of the three monocyte 
subsets, monocytes perturbations in HIV-1-infected indi-
viduals still existed after cART (Figures 1B,C). The intermediate 
CD14++CD16+ monocytes are inversely correlated with CD4 
cell counts (Figure 1E) and the CD4/CD8 ratio (Figure 1F).
Perturbations of Monocyte Phenotypes in 
hiV-1-infected individuals
To characterize the phenotypic changes of the three monocyte 
subsets, we analyzed the expression pattern of plasma sCD163 
and the following surface markers: scavenger receptors CD163 
(Figures 2A–C) and activation and maturation marker HLA-DR. 
Both the median fluorescence intensity (MFI) of surface CD163 
on intermediate CD14++CD16+ monocytes and the concentra-
tions of plasma sCD163 in AHI and CHI&ART− individuals 
are significantly higher than those in HC (Figures  2B,D). A 
significant decrease in plasma sCD163 levels and intermediate 
monocyte surface CD163 density is found in the chronic HIV-
1-infected individuals after cART, but surface CD163 density on 
intermediate monocytes and sCD163 levels in CHI&ART+ still 
higher than those in HC (Figures 2B,D). In acute HIV-1-infected 
patients, surface CD163 density on intermediate monocytes 
is higher than those in HC but lower than those in chronic 
HIV-1-infected individuals without cART. The concentrations 
of plasma sCD163 are positively correlated with the frequency 
of intermediate CD14++CD16+ monocytes (Figure  2E), but 
inversely correlated with classical CD14++CD16− monocytes 
(Figure 2F).
Figure 3 displays the dynamic changes of monocyte surface 
marker HLA-DR and its association with disease progression. The 
MFI of HLA-DR on intermediate CD14++CD16+ and classical 
CD14++CD16− monocytes in acute HIV-1-infected patients is 
significantly higher than that in HC (Figures 3B,C). The HLA-DR 
density on intermediate CD14++CD16+ monocytes is inversely 
correlated with the CD4+ cell counts (Figure 3D).
FigUre 1 | Perturbations of the three monocyte subsets in hiV-1-infected individuals. (a) The gating strategy for analysis of classical CD14++CD16−, 
intermediate CD14++CD16+, and non-classical CD14+CD16++ monocyte subsets is indicated. Frequencies of CD14+CD16++ (B), CD14++CD16+ (c), and 
CD14++CD16− (D) monocytes were analyzed by flow cytometry in healthy controls (HC), the patients with acute HIV-1 infection (AHI), chronic HIV-1-infected 
cART-naïve patients (CHI&ART-), and chronic HIV-1-infected patients with undetectable viral load after cART (CHI&ART+). All p values were calculated using an 
ANOVA, Student’s t-test, or the Mann–Whitney U test, *p < 0.05, **p < 0.01. Correlations between the frequency of the CD14++CD16+ monocytes and CD4 T cell 
counts (e) as well as the CD4/CD8 ratio (F) calculated by the Spearman correlation test (HC, AHI, CHI&ART−, and CHI&ART+ groups).
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The association between Monocyte 
subsets and iFn-γ, il-4, il-17, and TnF-α 
Producing cD4+ T cells
The gating strategy of the IFN-γ, IL-4, IL-17, and TNF-α produc-
ing CD4+ T cells is shown in Figure 4A. Compared with HC, 
chronic HIV-1-infected individuals without cART have a lower 
frequency of IFN-γ producing CD4+ T cells (Figure 4B) but a 
higher frequency of IL-4 producing CD4+ T cells (Figure 4C). 
The frequency of IL-17 (Figure 4D) and TNF-α producing CD4+ 
T cells (Figure 4E) in chronic HIV-1-infected individuals without 
cART is higher than that in HC. The frequency of IL-4 producing 
CD4+ T cells is negatively associated with CD4+ T cell counts 
(Figure 4F) as well as with the CD4/CD8 ratio (Figure 4G).
Next, correlation analyses are performed between monocyte 
subsets and the IFN-γ, IL-4, IL-17, and TNF-α producing 
CD4+ T cells in HIV-1-infected patients. The frequency of the 
non-classical monocyte CD14+CD16++ subsets is positively 
associated with the percentage of IFN-γ (Figure 5A) and TNF-α 
(Figure 5B) producing CD4+ T cells, but the frequency of the 
classical monocyte (CD14++CD16−) subsets is negatively 
associated with the percentage of IFN-γ (Figure 5E) and TNF-α 
producing CD4+ T  cells (Figure  5F). In contrast to the non-
classical CD14+CD16++ and classical CD14++CD16− mono-
cyte subsets, the frequency of the intermediate CD14++CD16+ 
monocyte subsets is positively associated with the frequency 
of IFN-γ (Figure  5C) and IL-4 (Figure  5D) producing CD4+ 
T  cells. The associations between monocyte subsets and the 
IFN-γ, IL-4, IL-17, and TNF-α producing CD4+ T  cells are 
further analyzed in AHI (Figure S1 in Supplementary Material), 
CHI&ART− (Figure S2 in Supplementary Material) and 
CHI&ART+ (Figure S3 in Supplementary Material) patients, 
separately. In AHI patients, the frequency of the intermediate 
CD14++CD16+ monocyte subsets is positively associated with 
the frequency of IL-4 (Figure S1D in Supplementary Material), 
whereas this subset is positively associated with the percentage of 
FigUre 2 | Perturbations of surface cD163 on the three monocyte subsets and soluble cD163 in hiV-1-infected individuals. The median fluorescence 
intensity of surface CD163 on the CD14+CD16++ (a), CD14++CD16+ (B), and CD14++CD16− (c) monocytes in healthy controls (HC), the patients with acute 
HIV-1 infection (AHI), chronic HIV-1-infected cART-naïve patients (CHI&ART−), and chronic HIV-1-infected patients with undetectable viral load after cART 
(CHI&ART+). The concentrations of plasma sCD163 (D) in HC, AHI, CHI&ART−, and CHI&ART+. All p values were calculated using an ANOVA, Student’s t-test, or 
the Mann–Whitney U test, *p < 0.05, **p < 0.01. Correlations between the concentrations of plasma sCD163 and the frequency of CD14++CD16+ monocytes (e), 
as well as CD14++CD16− monocytes (F) calculated by the Spearman correlation test (HC, AHI, CHI&ART−, and CHI&ART+ groups).
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IFN-γ (Figure S2C in Supplementary Material) and IL-4 (Figure 
S2D in Supplementary Material) producing CD4+ T  cells in 
CHI&ART− patients. However, in CHI&ART+ patients, there 
is no association between monocyte subsets and the IFN-γ, 
IL-4, IL-17, and TNF-α producing CD4+ T cells (Figure S3 in 
Supplementary Material).
DiscUssiOn
In the study, we evaluated the dynamic changes of monocyte 
subsets and their surface markers in acute and chronic HIV-1-
infected individuals, we also analyzed the association between 
monocyte subsets and Th cell differentiation. We found that 
in the acute HIV-1-infected individuals, the frequency of the 
intermediate CD14++CD16+ monocyte subsets, the HLA-DR 
density and CD163 density on CD14++CD16+ monocytes, 
and plasma CD163 were significantly higher than those in HC, 
but lower than those in chronic HIV-1-infected individuals. 
Intermediate CD14++CD16+ monocytes and their HLA-DR 
expression on intermediate CD14++CD16+ monocytes were 
inversely correlated with the CD4 cell counts, and the intermedi-
ate CD14++CD16+ monocytes were positively correlated with 
plasma sCD163. The frequency of IL-4 producing CD4+ T cells 
is negatively associated with CD4 cell counts as well as with the 
CD4/CD8 ratio. In contrast to non-classical CD14+CD16++ and 
classical CD14++CD16− monocyte subsets, the frequency of the 
intermediate CD14++CD16+ monocytes was positively associ-
ated with the frequency of IFN-γ and IL-4 producing CD4+ T cells 
in HIV-1-infected patients. The intermediate CD14++CD16+ 
monocyte subsets were positively associated with IFN-γ 
(CHI&ART− group) and IL-4 (AHI and CHI&ART− groups) 
producing CD4+ T cells. There was no association between the 
monocyte subsets and T helper cell responses in CHI&ART+. 
Intermediate monocyte subsets, surface CD163 density on inter-
mediate monocytes, and plasma sCD163 levels in CHI&ART+ 
still higher than those in healthy control, abnormalities of the 
three monocyte subsets still existed despite suppression of HIV 
after cART.
Our findings indicated that monocytes were heterogene-
ous with subset-specific phenotypes and functions during 
HIV-1 infection, intermediate CD14++CD16+ monocytes 
were correlated with disease progression in acute and chronic 
HIV-1-infected individuals, and the three monocyte subsets 
played different roles in Th cell differentiation in HIV-1-infected 
patients. The abnormalities of three monocyte subsets may be 
related to chronic immune activation despite suppression of HIV 
after cART.
Based on the expression of the CD14 and CD16 antigen, 
human blood monocytes were initially classified into two 
subsets: CD14+CD16− and CD14+CD16+ monocyte subsets 
(17). Recently, monocytes have been subdivided into three 
subsets by official nomenclature, each subset displays different 
FigUre 3 | Perturbations of surface hla-Dr on the three monocyte subsets in hiV-1-infected individuals. The median fluorescence intensity (MFI) of 
surface HLA-DR on CD14+CD16++ (a), CD14++CD16+ (B), and CD14++CD16− (c) monocytes in healthy controls (HC), the patients with acute HIV-1 infection 
(AHI), chronic HIV-1-infected cART-naïve patients (CHI&ART−), and chronic HIV-1-infected patients with undetectable viral load after cART (CHI&ART+). All p values 
were calculated using an ANOVA, Student’s t-test, or the Mann–Whitney U test, *p < 0.05, **p < 0.01. Correlations between HLA-DR MFI on CD14++CD16+ 
monocytes and the CD4 cell counts (D) calculated by the Spearman correlation test (HC, AHI, CHI&ART−, and CHI&ART+ groups).
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cytokine profiles and immune functions. Classical monocytes 
CD14++CD16− play crucial roles in defending against micro-
bial pathogens, intermediate CD14++CD16+ monocytes are 
associated with antigen presentation and inflammatory, and 
non-classical CD14+CD16++ monocytes exhibit patrolling 
properties (18). A strong increase of intermediate and a concomi-
tant decrease of classical monocytes has been found in patients 
with rheumatoid arthritis (19). Similar to rheumatoid arthritis 
patients, in this study, an expansion of intermediate monocytes 
and a reduction of classical monocytes were found in acute and 
chronic HIV-1-infection. cART produces a profound suppression 
of HIV replication but fails to eliminate chronic immune activa-
tion completely, and the persistent hyperactivity is associated 
with the emergence of non-AIDS morbidity (20). Perturbations 
of the three monocyte subsets were found in this study despite 
the suppression of HIV after cART, which may be responsible for 
chronic immune activation. The expansion of the intermediate 
monocytes may be due to an enhanced survival upon HIV-1 
infection (21) and the upregulation of surface CD16 on the clas-
sical subsets (22).
Burdo et al. showed that sCD163 levels were positively cor-
related with CD14+CD16+ monocytes (23). CD14+CD16+ 
monocytes were further subdivided into CD14++CD16+ and 
CD14+CD16++ subsets. We found that plasma sCD163 was 
only positively correlated with the intermediate CD14++CD16+ 
subsets, and there was no association between plasma sCD163 
and the non-classical CD14++CD16+ subsets. HIV-1-infected 
individuals after cART had higher levels of plasma sCD163 than 
those of HC, which indicated an important role of activated 
monocytes in HIV-1-related chronic immune activation. In the 
study, we found that the MFI of HLA-DR on intermediate mono-
cytes in acute HIV-1-infected patients was significantly higher 
than that in HC, which implied that intermediate monocytes 
have a crucial role in regulating the adaptive immune responses 
in acute HIV-1 infection.
Monocytes have many immunological functions including 
antigen presentation, which makes them a link between the 
innate and adaptive immune systems. Th1, Th2, and Th17 CD4+ 
T  cells are characterized exclusively by differences in cytokine 
expression: Th1 cells produce IL-2, IL-12, and interferon IFN-γ, 
Th2 cells express IL-4, IL-5, and IL-13, and Th17 cells produce 
IL-17, IL-17F, and IL-22. The dynamic changes of Th1, Th2, and 
Th17 in HIV-1-infected individuals have been reported by several 
groups: a reduced percentage of IFN-γ (Th1) producing cells and 
an increased percentage of IL-4 (Th2) producing cells (24) as well 
as conflicting results regarding IL-17 producing cells (25, 26). 
Human peripheral monocytes have been subdivided into three 
subsets with specific functions. In this study, we found that the 
percentages of IFN-γ and TNF-α producing CD4+ T cells were 
positively associated with the non-classical CD14+CD16++ 
FigUre 4 | Perturbations of iFn-γ, interleukin (il)-4, il-17, and TnF-α producing cD4+ T cells in hiV-1-infected individuals. Intracellular IFN-γ, IL-4, 
IL-17, and TNF-α staining was performed using peripheral blood mononuclear cells (PBMCs) after stimulation with PMA, ionomycin, and brefeldin A for 5 h. The 
gating strategy is indicated (a). Frequencies of IFN-γ (B), IL-4 (c), IL-17 (D), and TNF-α (e) producing CD4+ T cells analyzed by flow cytometry in healthy controls 
(HC), chronic HIV-1-infected cART-naïve patients (CHI&ART−), and chronic HIV-1-infected patients with undetectable viral load after cART (CHI&ART+). All p values 
were calculated using an ANOVA, Student’s t-test, or the Mann–Whitney U test, *p < 0.05, **p < 0.01. Correlations between the frequencies of IL-4 producing 
CD4+ T cells and CD4+ T cell counts (F) as well as the CD4/CD8 ratio (g) calculated by the Spearman correlation test (HC, AHI, CHI&ART−, and CHI&ART+ 
groups).
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FigUre 5 | correlations between monocyte subsets and the frequencies of iFn-γ, interleukin (il)-4, il-17, and TnF-α producing cD4+ T cells in 
hiV-1-infected individuals intracellular iFn-γ, il-4, il-17, and TnF-α staining was performed using peripheral blood mononuclear cells (PBMcs) 
after stimulation with PMa, ionomycin, and brefeldin a for 5 h. The frequency of the CD14+CD16++ monocytes is positively associated with the 
percentage of IFN-γ (a) and TNF-α (B) producing CD4+ T cells, the frequency of CD14++CD16+ monocyte subsets is positively associated with the 
frequency of IFN-γ (c) and IL-4 (D) producing CD4+ T cells in HIV-1-infected patients. The frequency of CD14++CD16− monocytes is negatively associated 
with the percentage of IFN-γ (e) and TNF-α (F) producing CD4+ T cells. The association is calculated by the Spearman correlation test (AHI, CHI&ART−, and 
CHI&ART+ groups).
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monocyte subsets but were negatively associated with the 
percentages of the classical monocyte CD14++CD16− subsets. 
Compared with CD4 T cells co-cultured with CD16-derived den-
dritic cells (MoDC), CD4 T cells co-cultured with CD16+ MoDC 
secreted more IL-4 (27). Here, we showed an increased frequency 
of IL4 producing CD4+ T  cells in HIV-1-infected individuals, 
and the frequency of IL4 producing CD4+ T cells was negatively 
associated with CD4 cell counts as well as with the CD4/CD8 
ratio. The intermediate CD14++CD16+ monocyte subsets were 
positively associated with IFN-γ (CHI&ART− group) and IL-4 
(AHI and CHI&ART− groups) producing CD4+ T cells. cART 
lead to virologic suppression and reduction of persistent immune 
activation, despite the abnormalities of the three monocyte subsets 
in individuals on cART, the associations between the monocyte 
subsets and the IFN-γ, IL-4, IL-17, and TNF-α producing CD4+ 
T cells have not been found in HIV-1-infected patients on cART 
with undetectable viral loads. Monocytes are precursors for DCs 
and macrophages, and blood monocytes can replenish special-
ized macrophages and DCs on demand (28). Compared with 
HIV-1-treated monocytes, HIV-1-treated MoDCs have different 
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effects on IL17+CD4+ T cells (29). An in vitro PBMC stimula-
tion culture system was used in this study, in which PBMCs were 
stimulated with PMA/ionomycin. Direct contact of monocytes 
and T cells is important for T cell differentiation (30), and the 
monocytes and T  cell co-culture system will be used in future 
studies to better understand the roles of monocytes in Th cell 
differentiation.
In summary, we evaluated the perturbations of monocyte 
subsets and their association with Th cell differentiation in 
acute and chronic HIV-1-infected individuals. Our observations 
provide new insight into the roles of monocyte subsets in HIV 
pathogenesis, particularly during AHI, and our findings may be 
helpful for the treatment of HIV-related immune activation.
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